| VYNE Therapeutics Inc. - Common Stock (NQ:VYNE)Price and VolumeDetailed Quote
 Top NewsMore NewsPerformanceMore NewsRead More
    12 Health Care Stocks Moving In Monday's Pre-Market Session
     August 04, 2025 
    Gold Gains 1%; Wingstop Shares Spike Higher
     July 30, 2025 
    US Stocks Edge Higher; Kraft Heinz Earnings Top Views
     July 30, 2025 
    These stocks are moving in today's pre-market session
     July 30, 2025 
    Here are the top movers in Thursday's session.
     June 26, 2025 
    These stocks are moving in today's pre-market session
     June 04, 2025 
    Top stock movements in today's session.
     April 25, 2025 
    12 Health Care Stocks Moving In Friday's Intraday Session
     April 25, 2025 
    There are notable gap-ups and gap-downs in today's session.
     April 25, 2025 Frequently Asked QuestionsIs VYNE Therapeutics Inc. - Common Stock publicly traded? Yes, VYNE Therapeutics Inc. - Common Stock is publicly traded. What exchange does VYNE Therapeutics Inc. - Common Stock trade on? VYNE Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market What is the ticker symbol for VYNE Therapeutics Inc. - Common Stock? The ticker symbol for VYNE Therapeutics Inc. - Common Stock is VYNE on the Nasdaq Stock Market What is the current price of VYNE Therapeutics Inc. - Common Stock? The current price of VYNE Therapeutics Inc. - Common Stock is 0.3664 When was VYNE Therapeutics Inc. - Common Stock last traded? The last trade of VYNE Therapeutics Inc. - Common Stock was at 10/30/25 04:00 PM ET What is the market capitalization of VYNE Therapeutics Inc. - Common Stock? The market capitalization of VYNE Therapeutics Inc. - Common Stock is 18.87M How many shares of VYNE Therapeutics Inc. - Common Stock are outstanding? VYNE Therapeutics Inc. - Common Stock has 19M shares outstanding. 
   Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service. 
  © 2025 FinancialContent. All rights reserved.
  | 
 | ||||||||||||||||||||||||